A) beta-carotene.
B) insulin.
C) human growth hormone.
D) vitamin A.
E) Factor VIII.

A) have the same properties as embryonic stem cells.
B) are pluripotent.
C) are isolated from developing embryos.
D) have not been used to treat diseases.
E) are multipotent.

A) production of clotting factors for treating patients with hemophilia.
B) production of recombinant insulin for treating diabetic patients.
C) increasing the number of organs available for transplant.
D) production of human growth hormone in large quantities.
E) All of these are valuable contributions of recombinant technology.